Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

• Lizhong Ding,
• Lizhong Ding,
• Lu Sun,
• Lu Sun,
• Melissa T. Bu,
• Yanjun Zhang,
• Yanjun Zhang,
• Lauren N. Scott,
• Robert M. Prins,
• Robert M. Prins,
• Robert M. Prins,
• Robert M. Prins,
• Maureen A. Su,
• Maureen A. Su,
• Maureen A. Su,
• Maureen A. Su,
• Melissa G. Lechner,
• Melissa G. Lechner,
• Willy Hugo,
• Willy Hugo,
• Willy Hugo

Affiliations

Lizhong Ding

Department of Medicine, Division of Dermatology, University of California, Los Angeles, Los Angeles, CA, United States

Lizhong Ding

Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, CA, United States

Lu Sun

Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, CA, United States

Lu Sun

Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, United States

Melissa T. Bu

Department of Medicine, Division of Dermatology, University of California, Los Angeles, Los Angeles, CA, United States

Yanjun Zhang

Department of Medicine, Division of Dermatology, University of California, Los Angeles, Los Angeles, CA, United States

Yanjun Zhang

State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Lauren N. Scott

Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of California, Los Angeles, Los Angeles, CA, United States

Robert M. Prins

Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, CA, United States

Robert M. Prins

Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, United States

Robert M. Prins

Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, United States

Robert M. Prins

Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States

Maureen A. Su

Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, CA, United States

Maureen A. Su

Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States

Maureen A. Su

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States

Maureen A. Su

Department of Pediatrics, Division of Pediatric Endocrinology, University of California, Los Angeles, Los Angeles, CA, United States

Melissa G. Lechner

Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of California, Los Angeles, Los Angeles, CA, United States

Melissa G. Lechner

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States

Willy Hugo

Department of Medicine, Division of Dermatology, University of California, Los Angeles, Los Angeles, CA, United States

Willy Hugo

Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, CA, United States

Willy Hugo

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States